EWG vs XBI
iShares MSCI Germany ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.49% for EWG.
- • EWG pays a higher dividend yield (2.01%).
Side-by-side metrics
| Metric | EWG | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.01% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $1.58B | $10.73B |
YTD return | -0.87% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 1.10 |
P/E ratio | 17.59 | — |
Last price | $41.60 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
EWG top holdings
| SIE.DE | Siemens AG | 12.63% |
| ALV.DE | Allianz SE | 9.53% |
| SAP.DE | SAP SE | 8.46% |
| ENR.DE | Siemens Energy AG Ordinary Shares | 7.77% |
| IFX.DE | Infineon Technologies AG | 6.45% |
| DTE.DE | Deutsche Telekom AG | 4.95% |
| MUV2.DE | Munchener Ruckversicherungs-Gesellschaft AG | 3.86% |
| DBK.DE | Deutsche Bank AG | 3.25% |
| DHL.DE | Deutsche Post AG | 2.95% |
| BAYN.DE | Bayer AG | 2.88% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EWG
EWG (iShares MSCI Germany ETF) is German large and mid-cap equities. Managed by iShares, the fund carries $1.6B in assets under management, an expense ratio of 0.49%, a dividend yield of 2.01%. Its largest holding is Siemens AG (SIE.DE), which represents 12.6% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.